|
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
|
7K99CA158065-02
|
$100,961
|
$100,961
|
Rink, Lori
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$422,717
|
$253,630
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-11
|
$7,000
|
$700
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$58,774
|
$58,774
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S1
|
$12,500
|
$1,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S2
|
$12,459
|
$997
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-38
|
$5,870,229
|
$469,618
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-27
|
$1,397,496
|
$13,975
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$745
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$58,013
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
Uganda-UCSF Research Training in HIV-Associated Malignancies
|
3D43CA153717-03S1
|
$233,333
|
$233,333
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor and Metastasis Therapy
|
ZIA BC 011024
|
$381,545
|
$305,236
|
Khanna, Chand
|
CCR (NCI)
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$381,545
|
$381,545
|
Khanna, Chand
|
CCR (NCI)
|
|
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis
|
5K08CA138764-05
|
$179,280
|
$179,280
|
Jones, Kevin
|
UNIVERSITY OF UTAH
|
|
Trans-splicing of RNA in Endometrail Stroma and Other Tissues
|
5R01CA139102-05
|
$306,332
|
$61,266
|
Sklar, Jeffrey
|
YALE UNIVERSITY
|
|
Training In Tumor Virology
|
5T32CA115299-08
|
$321,407
|
$64,281
|
Robertson, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$527,328
|
$52,733
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$724,380
|
$181,095
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-14
|
$1,723,723
|
$310,270
|
Herschman, Harvey
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING
|
5R01CA043059-25
|
$329,891
|
$164,946
|
SCHREIBER, ROBERT
|
WASHINGTON UNIVERSITY
|
|
The role of pRb-dependent Ihh in osteogenesis and osteosarcoma
|
5F31CA168132-02
|
$38,188
|
$19,094
|
Bryan, Crystal
|
TUFTS UNIVERSITY BOSTON
|
|
The Role of miRNA-mediated RNAI in the Biology of Cancer
|
ZIA BC 010612
|
$133,707
|
$26,741
|
Caplen, Natasha
|
CCR (NCI)
|
|
The Role of JAB1 in osteosarcoma pathogenesis
|
1R03CA175874-01
|
$79,063
|
$79,063
|
Zhou, Guang
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Role of Eya3 as a downstream target of EWS Fli1 in Ewings Sarcoma
|
5F30CA165873-02
|
$23,307
|
$23,308
|
Robin, Tyler
|
UNIVERSITY OF COLORADO DENVER
|
|
The Induction of Gene-specific RNAi Against Cancer-associated Genes
|
ZIA BC 010613
|
$222,844
|
$11,142
|
Caplen, Natasha
|
CCR (NCI)
|
|
The ARF Tumor Suppressor
|
5R01CA139319-04
|
$325,422
|
$81,356
|
MURPHY, MAUREEN
|
WISTAR INSTITUTE
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$109,708
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-03
|
$329,635
|
$247,226
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell Death
|
5K99CA166517-02
|
$124,994
|
$31,249
|
Dixon, Scott
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Targeting Kinases that Phosphorylate the KSHV LANA Chromatin Binding Domain
|
5R21CA171814-02
|
$165,605
|
$165,605
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-03
|
$287,409
|
$143,705
|
Dittmer, Dirk
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Studying the role of KSHV-encoded miRNAs
|
2R01CA119917-06
|
$299,900
|
$299,900
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study the roles of p53 and p53 mutants in mesenchymal stem cells
|
ZIA BC 011504
|
$375,258
|
$375,258
|
Huang, Jing
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$591,988
|
$177,596
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$70,831
|
$7,083
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors
|
ZIA BC 011105
|
$141,661
|
$53,831
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-13
|
$328,590
|
$164,295
|
Nicholas, John
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$287,892
|
$287,892
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of Childhood Sarcomas
|
1P01CA165995-01A1
|
$1,505,297
|
$1,505,297
|
HOUGHTON, PETER
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$239,910
|
$239,910
|
Barr, Frederic
|
CCR (NCI)
|
|
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
|
2R01CA133404-06
|
$459,706
|
$229,853
|
Sharp, Phillip
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Strategies to Improve Kaposi's Sarcoma Outcomes in Zimbabwe
|
5R01CA172050-02
|
|
$0
|
Campbell, Thomas
|
UNIVERSITY OF COLORADO DENVER
|
|
Stanford University Cancer Center
|
3P30CA124435-07S1
|
$75,000
|
$1,500
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-07
|
$2,890,663
|
$57,813
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
2P50CA127003-06A1
|
$2,150,500
|
$365,585
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INST
|
|
SPORE in Soft Tissue Sarcoma
|
5P50CA140146-04
|
$2,136,282
|
$2,050,831
|
SINGER, SAMUEL
|
SLOAN-KETTERING INST CAN RES
|
|
Solid Tumors
|
ZIA SC 006891
|
$425,633
|
$425,633
|
Helman, Lee
|
CCR (NCI)
|
|
Small Molecule Activators of Procaspases as Anti-Cancer Agents
|
2R01CA120439-06A1
|
$451,618
|
$225,809
|
Hergenrother, Paul
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
Sleeping Beauty for uncovering cancer genes in mice
|
5R01CA113636-07
|
$237,060
|
$237,060
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA
|
Total relevant funding to Sarcoma for this search: $59,276,593
|